58
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Carbamazepine Interference with an Immune Assay for Tricyclic Antidepressants in Plasma

, , , , , & show all
Pages 109-113 | Published online: 29 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Monika Wieczerzak, Błażej Kudłak & Jacek Namieśnik. (2015) Environmentally Oriented Models and Methods for the Evaluation of Drug × Drug Interaction Effects. Critical Reviews in Analytical Chemistry 45:2, pages 131-155.
Read now
Robert G. Hendrickson$suffix/text()$suffix/text() & Anthony P. Morocco$suffix/text()$suffix/text(). (2003) Quetiapine Cross-Reactivity Among Three Tricyclic Antidepressant Immunoassays. Journal of Toxicology: Clinical Toxicology 41:2, pages 105-108.
Read now
John Fisher. (1998) Immunoassay Drug Screen Results. Journal of Toxicology: Clinical Toxicology 36:1-2, pages 115-116.
Read now

Articles from other publishers (25)

Amitava Dasgupta & Matthew D. Krasowski. 2020. Therapeutic Drug Monitoring Data. Therapeutic Drug Monitoring Data 199 227 .
JamirP Rissardo & AnaL Fornari Caprara. (2019) Carbamazepine-associated urinary incontinence: A case report and literature review. International Journal of Medicine and Health Development 24:2, pages 114.
Crossref
Karen E. Moeller, Julie C. Kissack, Rabia S. Atayee & Kelly C. Lee. (2017) Clinical Interpretation of Urine Drug Tests. Mayo Clinic Proceedings 92:5, pages 774-796.
Crossref
Zachary J. Nelson, Samuel J. Stellpflug & Kristin M. Engebretsen. (2016) What Can a Urine Drug Screening Immunoassay Really Tell Us?. Journal of Pharmacy Practice 29:5, pages 516-526.
Crossref
S.T. Alrashood. 2016. 133 321 .
Amitava Dasgupta. 2016. Clinical Challenges in Therapeutic Drug Monitoring. Clinical Challenges in Therapeutic Drug Monitoring 17 44 .
Christophe Bazin, Nathalie Chèze, Amine Mihoubi, Dabor Résière, Hervé Gourlain & Laurent Havard. (2015) Cyclic antidepressants screening in emergency toxicology: Immunoassay study through cross-reactivity and molecular structures. Toxicologie Analytique et Clinique 27:2, pages 81-87.
Crossref
M. L. Pan, W. Y. Lin, H. Y. Wang, S. C. Tsai, P. F. Hsieh, Y. L. O. Su & P. W. Huang. (2013) Determination of carbamazepine: a comparison of the differential pulse voltammetry (DPV) method and the immunoassay method in a clinical trial. Journal of Analytical Chemistry 69:1, pages 57-61.
Crossref
Amitava Dasgupta. (2012) Impact of Interferences Including Metabolite Crossreactivity on Therapeutic Drug Monitoring Results. Therapeutic Drug Monitoring 34:5, pages 496-506.
Crossref
Amitava Dasgupta. 2012. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring 293 322 .
Uttam Garg & Angela Ferguson. 2012. Therapeutic Drug Monitoring. Therapeutic Drug Monitoring 269 289 .
Michael Levine, Daniel E. Brooks, Carrie A. Truitt, Brian J. Wolk, Edward W. Boyer & Anne-Michelle Ruha. (2011) Toxicology in the ICU. Chest 140:3, pages 795-806.
Crossref
H. Y. Wang, M. L. Pan, Y. L. Oliver Su, S. C. Tsai, C. H. Kao, S. S. Sun & W. Y. Lin. (2011) Comparison of Differential Pulse Voltammetry (DPV)?a new method of carbamazepine analysis?with Fluorescence Polarization Immunoassay (FPIA). Journal of Analytical Chemistry 66:4, pages 415-420.
Crossref
Calies Menard-Katcher, Fred M. Henretig & Kevin C. Osterhoudt. (2009) A 19-Month-Old Girl With Recurrent Illness. Pediatric Emergency Care 25:12, pages 869-871.
Crossref
Karen E. Moeller, Kelly C. Lee & Julie C. Kissack. (2008) Urine Drug Screening: Practical Guide for Clinicians. Mayo Clinic Proceedings 83:1, pages 66-76.
Crossref
Uttam Garg. 2008. Handbook of Drug Monitoring Methods. Handbook of Drug Monitoring Methods 148 163 .
Amitava Dasgupta & Pradip Datta. 2008. Handbook of Drug Monitoring Methods. Handbook of Drug Monitoring Methods 67 86 .
Mohsen Saidinejad, Terence Law & Michele Burns Ewald. (2007) Interference by Carbamazepine and Oxcarbazepine With Serum- and Urine-Screening Assays for Tricyclic Antidepressants. Pediatrics 120:3, pages e504-e509.
Crossref
D. ERIC BRUSH & CYNTHIA K. AARON. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose 537 548 .
Cornelia S. Seitz, Petra Pfeuffer, Petra Raith, Eva-B. Br?cker & Axel Trautmann. (2006) Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents. Annals of Allergy, Asthma & Immunology 97:5, pages 698-702.
Crossref
Loralie J. Langman & Bhushan M. Kapur. (2006) Toxicology: Then and now. Clinical Biochemistry 39:5, pages 498-510.
Crossref
E Martin Caravati, JoEtta M Juenke, Barbara I Crouch & Kathleen T Anderson. (2005) Quetiapine Cross-Reactivity with Plasma Tricyclic Antidepressant Immunoassays. Annals of Pharmacotherapy 39:9, pages 1446-1449.
Crossref
Amy Fleischman & Vincent W. Chiang. (2001) Carbamazepine Overdose Recognized by a Tricyclic Antidepressant Assay. Pediatrics 107:1, pages 176-178.
Crossref
Eran Kozer, Zul Verjee & Gideon Koren. (2000) Misdiagnosis of a Mexiletine Overdose Because of a Nonspecific Result of Urinary Toxicologic Screening. New England Journal of Medicine 343:26, pages 1971-1971.
Crossref
Michael E. Matos, Michele M. BurnsMichael W. Shannon. (2000) False-Positive Tricyclic Antidepressant Drug Screen Results Leading to the Diagnosis of Carbamazepine Intoxication. Pediatrics 105:5, pages e66-e66.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.